Femasys Corporation (FEMY): רווח למניה בשנים עשר החודשים האחרונים

Femasys Inc. is implementing automated lines for the sterile production of products. The sliding net profit per share snapshot visualizes financial stability, where -4.60 reflects the latest value of the metric. However, geopolitical tensions and Asian tariffs are increasing component costs, which is offset by an organic expansion strategy through clinic partnerships without conducting mergers.

Femasys Inc. monetizes the development of high-tech minimally invasive systems for gynecology. The efficiency of this model is quantified through the ratio of aggregate net income to the total number of shares. This metric measures the real return on each share of ownership, stripping profit of the impact of issuance. The trend of the rolling 12-month EPS reveals the actual viability of the business during periods of consolidation. The stability of this chart confirms the resilience of the company's operating cash flow.